SEC 13F Intelligence

Boxer Capital, LLC / GBTUSD

Boxer Capital, LLC’s Global Blood Therapeutics Inc Position

Does Boxer Capital, LLC own Global Blood Therapeutics Inc (GBTUSD)? Not currently — the last reported position was 250.0K shares worth $14M in Q3 2020; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$14M
Q3 2020
Shares
250.0K
% of Portfolio
+0.48%
Quarters Held
8
position exited

Position History GBTUSD

Reported value by quarter
Q4 ’18: $29MQ4 ’18Q1 ’19: $13MQ1 ’19Q2 ’19: $13MQ2 ’19Q3 ’19: $12MQ3 ’19Q4 ’19: $20MQ4 ’19Q1 ’20: $13MQ1 ’20Q2 ’20: $16MQ2 ’20Q3 ’20: $14MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2020250.0K$14M+0.48%
Q2 2020250.0K$16M+0.69%
Q1 2020250.0K$13M+0.87%
Q4 2019250.0K$20M+1.12%
Q3 2019250.0K$12M+0.88%
Q2 2019250.0K$13M+1.13%
Q1 2019250.0K$13M+1.53%
Q4 2018700.0K$29M+3.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of GBTUSD.